NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications

Aaron Bodansky,Sara E Vazquez,Janet Chou,Tanya Novak,Amer Al-Musa,Cameron Young,Margaret Newhams,Suden Kucukak,Laura D Zambrano,Anthea Mitchell,Chung-Yu Wang,Kristin Moffitt,Natasha B Halasa,Laura L Loftis,Stephanie P Schwartz,Tracie C Walker,Elizabeth H Mack,Julie C Fitzgerald,Shira J Gertz,Courtney M Rowan,Katherine Irby,Ronald C Sanders Jr,Michele Kong,Jennifer E Schuster,Mary A Staat,Matt S Zinter,Natalie Z Cvijanovich,Keiko M Tarquinio,Bria M Coates,Heidi R Flori,Mary K Dahmer,Hillary Crandall,Melissa L Cullimore,Emily R Levy,Brandon Chatani,Ryan Nofziger,Overcoming COVID-19 Network Study Group Investigators,,Raif S Geha,Joseph DeRisi,Angela P Campbell,Mark Anderson,Adrienne G Randolph,Masson Yates,Chelsea Smith,MattS Zinter,Gwenn McLaughlin,Margaret M Newhams,Hye Kyung Moon,Takuma Kobayashi,Jeni Melo,Sabrina R Chen,Supriya Behl,Noelle M Drapeau,Russell J McCulloh,Ryan A Nofziger,Mary Allen Staat,Chelsea C Rohlfs,Nelson Reed

DOI: https://doi.org/10.1016/j.jaci.2022.11.020

Abstract:Background: Autoantibodies against type I IFNs occur in approximately 10% of adults with life-threatening coronavirus disease 2019 (COVID-19). The frequency of anti-IFN autoantibodies in children with severe sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is unknown. Objective: We quantified anti-type I IFN autoantibodies in a multicenter cohort of children with severe COVID-19, multisystem inflammatory syndrome in children (MIS-C), and mild SARS-CoV-2 infections. Methods: Circulating anti-IFN-α2 antibodies were measured by a radioligand binding assay. Whole-exome sequencing, RNA sequencing, and functional studies of peripheral blood mononuclear cells were used to study any patients with levels of anti-IFN-α2 autoantibodies exceeding the assay's positive control. Results: Among 168 patients with severe COVID-19, 199 with MIS-C, and 45 with mild SARS-CoV-2 infections, only 1 had high levels of anti-IFN-α2 antibodies. Anti-IFN-α2 autoantibodies were not detected in patients treated with intravenous immunoglobulin before sample collection. Whole-exome sequencing identified a missense variant in the ankyrin domain of NFKB2, encoding the p100 subunit of nuclear factor kappa-light-chain enhancer of activated B cells, aka NF-κB, essential for noncanonical NF-κB signaling. The patient's peripheral blood mononuclear cells exhibited impaired cleavage of p100 characteristic of NFKB2 haploinsufficiency, an inborn error of immunity with a high prevalence of autoimmunity. Conclusions: High levels of anti-IFN-α2 autoantibodies in children and adolescents with MIS-C, severe COVID-19, and mild SARS-CoV-2 infections are rare but can occur in patients with inborn errors of immunity.